Nasdaq agrx.
If you would like to register as a market maker in AGRX, contact Nasdaq Trading Operations at +1 212 231 5100. Email Alert Subscriptions: Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets.
PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, …Investor Relations. Agile Therapeutics® is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet needs of today’s women. Our product and product candidates are designed to offer women more freedom and flexibility through additional contraceptive options.A high-level overview of Agile Therapeutics, Inc. (AGRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 ...
The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”
AGRX Option Chain. ... Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month ...Find the latest Earnings Report Date for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.
(NASDAQ: AGRX) current product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without ...Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's …AGRX Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. / PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of ...Find the latest Insider Activity data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.
PRINCETON, N.J., Feb. 21, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of 15 ...
PRINCETON, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on December 11, 2018, it met with the U.S. Food ...
Created with Sketch. when trading, helping you to optimize your price and have a successful order execution. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4 ...Apr 26, 2023 · PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it has received a notification letter from the ... Apr 19, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ... Track Agile Therapeutics Inc (AGRX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable …PRINCETON, N.J., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract based on the Phase 3 SECURE trial of its ...
Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow - Agile Therapeutics (NASDAQ:AGRX), Dare ...Le cours de l'action AGILE THERAPEUT AGRX sur Boursorama : historique de la cotation sur NASDAQ, graphique, actualités, consensus des analystes et ...Nov 19, 2023 · NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00. The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”PRINCETON, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that Al Altomari, Chairman and Chief ...PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its ...Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.
15 Jun 2023 ... Agile's Capital Raise Strategies In A Competitive Market: NASDAQ: $AGRX CEO Al Altomari's Approach. 80 views · 2 months ago #WomensHealth #AGRX
The Company’s common stock will open for trading on the Nasdaq Market on Wednesday, April 27, 2022 on a split-adjusted basis under the current trading symbol "AGRX."PRINCETON, N.J., April 22, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon ...Nov 10, 2023 · Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript. Published on November 10, 2023 at 10:20 am by Insider Monkey Transcripts in News, Transcripts. Amy Welsh: Yes. Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.PRINCETON, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on January 9, 2019 it received final meeting ...The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will ...The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”PRINCETON, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has ...
PRINCETON, N.J., July 23, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of ...
Shares of NASDAQ AGRX opened at $2.16 on Friday. Agile Therapeutics has a one year low of $1.65 and a one year high of $16.00. The firm has a market capitalization of $5.43 million, a PE ratio of -0.16 and a beta of 1.85. The business has a 50-day moving average price of $1.99 and a two-hundred day moving average price of $2.54.
The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the closing of its ...Agile Therapeutics, Inc., (Nasdaq: AGRX), a women's healthcare company, today announced an agreement with vitaCare Prescription Services, a wholly owned subsidiary of GoodRx, to expand patient ...Oct 21, 2022 · NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 Published. Oct 21, 2022 11:00am EDT. Benzinga Digital Content Studio--News Direct--Contact Details. PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ...AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Nov 10, 2023 · 10 Best Penny Stocks to Buy in July Agile Therapeutics, Inc. (NASDAQ:AGRX) Q1 2023 Earnings Call Transcript 5 Cheap Pharmaceutical Stocks For 2022 5 Best Penny Stocks to Buy and Hold According to ... PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the ...PRINCETON, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company, today announced positive top-line results from its ...Agile Therapeutics Inc (NASDAQ: AGRX) was in 6 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 15. Our calculations also showed that AGRX ...Nov 10, 2023 · And that’s a very complicated subject. Alfred Altomari Earnings Call Transcript Matt Riley NASDAQ:AGRX Q3 2023 Show more... Operator: Good morning, and welcome to the Agile Therapeutics Third ...
Agile Therapeutics, Inc. (NASDAQ:AGRX) is a New Jersey-based healthcare company focused on catering to the unmet demands of women by offering them various contraceptive options.Find the latest SEC Filings data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.PRINCETON, N.J., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today provided an update on Twirla for 2022 and its commercial plan for ...Instagram:https://instagram. under armour stock pricescoca cola celsiusc.m.iwhat banks give same day debit cards AGRX Sales Forecast. Next quarter’s sales forecast for AGRX is $9.20M with a range of $9.20M to $9.20M. The previous quarter’s sales results were $6.66M. AGRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.22% of the time in the same period. cmbs etfacb stocktwits Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information. Institutional ... Nov 19, 2023 · NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00. paramount + stock The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”